After Two Decades in the DNA Synthesis Space, I’m Joining a Startup That’s Changing the Whole Field I’m really excited to be joining Ansa Biotechnologies as the company’s chief operating officer. In this role, I’ll be able to use my expertise in DNA and gene synthesis technology and operations to he...

After 20+ years in DNA synthesis, Ansa’s new COO Matthias Arenskötter shares why the field needs a new approach, and how long, reliable DNA unlocks real design freedom.

📖 www.linkedin.com/pulse/after-...

We’re excited to welcome Matthias Arenskötter as Ansa’s new COO. With 20+ years in DNA synthesis+ deep expertise in scaling advanced manufacturing, Matthias will lead global ops across manufacturing, supply chain & QA as we meet rising demand for long, complex DNA.

🔗 ansabio.com/news-events/...

#Biosecurity isn’t a ‘nice to have’ in DNA synthesis. It’s a core responsibility in our field.

At Ansa, every DNA order is screened & verified before manufacturing begins, w/ automated sequence checks, expert review, and strong data security to protect sensitive designs.

👉 hubs.li/Q04869W-0

The biggest limitation in DNA synthesis isn’t cost. It’s:
• Sequence rejection
• Unpredictable timelines

🧪 Accessing complex DNA is only half the problem.
Getting it when you expect it is what keeps science moving.

📑 Read the Tech Note here: hubs.li/Q047n2hW0

#BIOsky

Move beyond limitations! When complexity stops others, we keep going. We’ve partnered with @ansabio.bsky.social to provide you with long, complex clonal DNA up to 50 kb. Expect fast turnaround, dependable delivery, and sequence-perfect DNA, so your boldest ideas don’t have to wait: idtb.io/07t7jr

📣 Our team is excited to share that our synthetic DNA contributed to a new study in Nature led by @arcinstitute.org introducing the Evo 2 genomic foundation model.

📑 Read the paper: lnkd.in/gxJS8rSJ

🧭 We didn’t set out to reinvent DNA synthesis.
We set out to solve a problem we experienced ourselves.

Want to understand the science behind Ansa’s approach, and why enzymatic synthesis changes what’s possible? Read on: ansabio.com/blog/ansas-e...

What’s possible today with large, complex DNA?

This on-demand webinar walks through a real-world case: a 23 kb dystrophin plasmid synthesized in 20 business days and deployed with AI-guided delivery vehicles.

👉Watch here: hubs.li/Q03Vg1SR0

#DNASynthesis #GeneTherapy

New synthetic phage platform could reshape antimicrobial therapy A new system lets researchers build and reprogram phage genomes from digital sequence data, potentially enabling scalable, customizable therapies for drug-resistant bacteria.

Drug Discovery News highlights an exciting advance from New England Bio Labs and Yale University: a synthetic phage engineering platform that enables phages to be designed and built entirely in the lab. Proud that Ansa could deliver the DNA for this study.
www.drugdiscoverynews.com/new-syntheti...

ICYMI: Last week’s #JPM event sponsored by Mithrl was a packed house with sharp insights on the future of AI in biology.

Leaders across pharma, biotech & AI, including Jason T. Gammack, shared what will drive the next era of therapeutic discovery.

👉 www.ansabio.com

ICYMI: We’re partnering with @ansabio.bsky.social to provide customers with access to long, #complexDNA, ranging from 100 bp to 50 kb! Take a look at how this collaboration has delivered value to Manos Papadakis, Senior Research Scientist, @dsmfirmenich.bsky.social. 👇

Read more: idtb.io/c2tiva

New partnership announcement! 🤝
We’re proud to collaborate with @ansabio.bsky.social to provide our customers with access to long, complex #clonalDNA ranging from 100 bp to 50 kb. Read more here: idtb.io/xfs37g

#SyntheticBiology #DNASynthesis #synbio #lifesciencesnews

🚀 Big news: Ansa is partnering with @idtdna.bsky.social to expand access to enzymatic DNA synthesis worldwide. IDT customers can now get sequence-perfect DNA constructs up to 50 kb with the speed and precision researchers trust.
🔗 hubs.ly/Q03-KKPM0

Attending #JPM26? Don’t miss hearing from Ansa CEO Jason T. Gammack at this JPM Healthcare Satellite Event!

📅 Wed, Jan 14 | 5–8 PM
📍 100 Montgomery St, Ste. 1200, San Francisco
Register: bit.ly/44wDkOZ

Join us for Happy Hour + Panel Discussions on AI & Biopharma Innovation.

#BIOsky #synbio

Don't wait on slow, unreliable DNA synthesis.

✅ Order whole pathways & multi-gene systems as single constructs
✅ Tackle projects that were once “unsynthesizable”
✅ Design from biology-first principles w/ the confidence that complex constructs will arrive on time & exactly as specified

ansabio.com

🔎 𝗣𝗥𝗘𝗦𝗦 𝗦𝗣𝗢𝗧𝗟𝗜𝗚𝗛𝗧

We are excited to see @GenomeWeb spotlight Ansa and our mission to reshape what is possible in DNA synthesis.

👉 Read the article: hubs.li/Q03YDk7_0

What would you build with 50 kb of accurate DNA delivered in under a month?

See how @appliedstemcell.bsky.social achieved a precise 50 kb knock-in using TARGATT™ + Ansa DNA synthesis.

📄 bit.ly/49jsX3G 🧪

In cell and gene therapy, one missing piece can derail your whole project. At Ansa, we deliver complex sequences like ITRs, regulatory regions & long inserts, so you can focus on function, not fabrication.

👉 lnkd.in/gfEe2h4U

🧪 #BIOsky

Ending The Waiting Game: How Ansa Biotechnologies Guarantees are Turning DNA Synthesis Into A Predictable Industry Join SynBioBeta, the global community of biological engineers, entrepreneurs, investors, and innovators working to make biology easier to engineer.

Customers deserve the same confidence ordering DNA as any other reagent, says Ansa CEO Jason T Gammack.

In this #SynBioBeta feature, he shares how Ansa delivers >97% fulfillment on long, complex constructs & why the future is shifting from buying genes to buying genomes.

🧪 bit.ly/4iX4qVE

𝗡𝗘𝗪 𝗔𝗗𝗗𝗜𝗧𝗜𝗢𝗡 𝗧𝗢 𝗧𝗛𝗘 𝗧𝗘𝗔𝗠: We’re thrilled to announce the appointment of Geoff Hamilton as Ansa’s new Chief Financial Officer and Chief Business Officer.

🔗 Release: hubs.li/Q03Xvjkk0
🔎 Get to know Geoff: hubs.li/Q03Xvj3H0

Sick of scaling back experiments? We were, too. That’s why we founded a company to reimagine DNA synthesis from the ground up and to fundamentally change the status quo.

🧪 Experience a new kind of DNA provider: hubs.li/Q03grdRG0

#BIOsky #synbio

Ordering synthetic DNA? Don’t do it blind.

Get our free guide, which breaks down what to watch for before placing your next order—timelines, QC, complexity, and true cost—so you can make smarter choices with confidence.

👉 hubs.li/Q03WGW7k0

#synbio #BIOsky #syntheticDNA

NOW ON-DEMAND: Webinar for #genetherapy Innovators. featuring a collaboration w/ #EndoFold Bio that generated a full-length ~23 kb human dystrophin plasmid (including UTRs) in ~20 business days .

👉 Watch here: hubs.li/Q03Vg1SR0

#BIOsky #synbio 🧪

DNA Synthesis Just Hit Its Inflection Point … and Most of the Industry Isn’t Ready For decades, the DNA synthesis world has operated under a quiet rule: this terrible service is just the way it is. Deal with it.

Scientists no longer need to shrink their imagination to match the limitations of their synthesis suppliers' capabilities. Ansa CEO Jason T Gammack explains how we are flipping the "build vs. buy" equation & making programmable biology programmable.

www.linkedin.com/pulse/dna-sy...

#BIOsky #synbio

🌱 A greener way to make DNA: Ansa uses fully aqueous, enzyme-based synthesis—no harsh chemicals, less waste, and longer, cleaner constructs.

👉Learn more: ansabio.com/technology/?...

#synbio #BIOsky #sustainability #DNAsynthesis

Genome synthesis, assembly, and rebooting of therapeutically useful high G+C% mycobacteriophages | PNAS Bacteriophages show therapeutic promise for treating bacterial pathogens including nontuberculous mycobacteria (NTM). A major impediment is the pau...

🧪 From 𝗰𝗹𝗼𝗻𝗶𝗻𝗴 to 𝗽𝗿𝗶𝗻𝘁𝗶𝗻𝗴, the field just hit turbo mode. Introducing a PNAS paper in which scientists from Pitt Bio & New England Biolabs worked with Ansa to build fully synthetic mycobacteriophage genomes (viruses) from scratch.

www.pnas.org/doi/10.1073/...

#synbio #BIOsky

Ansa Biotechnologies <h2>Our Mission:</h2> <h2><em>Revolutionize the way we make DNA</em></h2> <p class="">Compared to reading or editing life’s code, writing new code from scratch has remained one of biotechnology’s most...

We are scaling like crazy and have several Manufacturing Associate positions open right now to keep up with the demand.

Please share with anyone who would be interested in joining our team during this exciting time!

job-boards.greenhouse.io/ansabiotechn...

#hiring #manufacturing #sciencejobs

𝗡𝗼𝘁𝗵𝗶𝗻𝗴 𝘀𝗽𝗲𝗮𝗸𝘀 𝗹𝗼𝘂𝗱𝗲𝗿 𝘁𝗵𝗮𝗻 𝗰𝘂𝘀𝘁𝗼𝗺𝗲𝗿 𝘀𝘂𝗰𝗰𝗲𝘀𝘀.
We're grateful for this ringing endorsement from Dr. Simon Shu-Yu Wu of @ASCAppliedStem.

👉 Learn more about XL Clonal DNA: ansabio.com/products/50kb/

🧪 We are proud to announce the launch of our 50kb Clonal DNA, the longest sequence=perfect synthetic DNA commercially available, in <25 days, backed by the industry's only On-Time Guarantee.

👉 ansabio.com/topic/news-e...

#BIOsky #SyntheticDNA

🧬 Finding the right vector just got easier — and faster.
Announcing Ansa’s new Catalog Vectors! Skip the upfront postage & paperwork. Simply upload your sequence file, select your vector, and Ansa will ship your completed DNA to you.

🔗 ansabio.com/products/vec...